The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This brief offers an overview of the new multilateral global health financing mechanism known as the Pandemic Fund, which is housed at the World Bank. The brief reviews the evolution of the Fund, its current financial status and donors, U.S. engagement, and policy issues going forward.
This brief provides an overview of the impact of mpox in the U.S. one year after a case of was identified domestically and the federal response to date, and discusses the future outlook.
In this Think Global opinion piece, Jennifer Kates and Kellie Moss discuss what could happen if the United States’ signature initiative on global health is not reauthorized.
Based on analysis of PEPFAR data, this data note presents an overview of who PEPFAR served in 2022, looking at gender, age, and other characteristics.
This Issue Brief reviews the history of Africa CDC, describing its structure, funding and operations to date, including U.S. government engagement, as well as challenges and opportunities for the institution moving forward.
This year, Congress will consider reauthorization of the President’s Emergency Plan for AIDS Relief (PEPFAR). This Policy Watch provides fast facts about the program and top issues related to its authorization and funding.
This analysis illustrates the potential total cost of Pfizer and Moderna COVID-19 vaccines, based on their publicly-announced expected prices, once they enter the U.S. commercial market. It compares the average price paid by the federal government for the COVID-19 bivalent boosters to the estimated average commercial prices across different scenarios.
As we mark three years since the WHO characterized COVID-19 as a pandemic, here are 10 key data points that illuminate the challenges, and progress, made to date.
In this commentary for Barron's, KFF's Cynthia Cox and Jennifer Kates explore what will happen with costs to COVID-19 vaccines for people with and without insurance once the relevant public health emergency ends on May 11.
This issue brief examines existing treaties and other global health agreements to assess whether they have been utilized for the COVID-19 pandemic response and whether they contain pandemic preparedness and response components in their mandates. The COVID-19 pandemic challenged and revealed gaps in global health governance systems, prompting stakeholders to reevaluate existing frameworks and discuss new agreements aimed at addressing future pandemics. To help inform these discussions, we evaluate existing global health agreements to assess their role in pandemic preparedness and response efforts, including the COVID-19 pandemic.
© 2025 KFF